Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Clinical trial status of pain control implant updated by CytoTherapeutics/Astra

Jan. 26, 1998

Neuroprotective effects of new PARS inhibitor

Jan. 26, 1998

Agents for schizophrenia without EPS disclosed by Warner-Lambert

Jan. 26, 1998

Antegren meets development criteria in phase II trial

Jan. 23, 1998

CRF antagonists patented by Pfizer

Jan. 23, 1998

Enantiomers of trans-benz[e]indoles selective for D3 receptors

Jan. 23, 1998

Orally active enkephalinase-inhibitory prodrug reported by Dainippon

Jan. 23, 1998

Titan reports results from preclinical Parkinson's trial

Jan. 22, 1998

HMR and Allelix end collaboration for treatment of schizophrenia

Jan. 22, 1998

HMR and Abbott sign marketing agreement for Anzemet

Jan. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Viva in vivo! At EHA, in vivo CAR T data continues to impress
BioWorld
Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...